JonathanBrettOrensMD

Critical Care Medicine

Professor of Medicine, Johns Hopkins University School of Medicine; Vice Chairman for Clinical Business Development-Department of Medicine Division of Pulmonary and Critical Care Medicine

Join to view full profile

Dr. Orens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Orens' full profile

Already have an account?

Office
601 North Caroline Street
Baltimore, MD 21287
Phone+1 410-614-4898

Fax+1 410-614-7008

Education & Training

University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
University of MarylandResidency, Internal Medicine, 1987 - 1991
University of Maryland School of MedicineClass of 1987

Certifications & Licensure

MD State Medical License 1988 - 2025
MI State Medical License 1991 - 1995
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
National Board of Physicians and Surgeons Critical Care Medicine
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Genome Transplant Dynamics Start of enrollment: 2015 Jun 25
Recruiting
Roles: Contact

Publications & Presentations

PubMed

1 citations
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
Michael B Keller, David Newman, Muhtadi Alnababteh, Lucia Ponor, Pali Shah
The Journal of Heart and Lung Transplantation. 2024-09-01
1 citations
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.
Michael B Keller, Junfeng Sun, Muhtadi Alnababteh, Lucia Ponor, Pali D Shah
Transplantation Direct. 2024-07-01
7 citations
Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.
Michael B Keller, Xin Tian, Moon Kyoo Jang, Rohan Meda, Ananth Charya
American Journal of Respiratory and Critical Care Medicine. 2024-05-15

Press Mentions

Covid Disease Damage Leading to 'Completely New Category' of Organ TransplantsApril 12th, 2021
Convalescent Plasma Used to Prevent Spread of COVID-19October 20th, 2020